| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 51.4% | 57/111 |
| Female | 47.7% | 53/111 |
| Indifferent | 0% | 0/111 |
| Unknown | 0.9% | 1/111 |
| General | ||
| 2.9% | 3/104 | |
| 9.6% | 10/104 | |
| 4.9% | 5/103 | |
| 26% | 27/104 | |
| 23.1% | 24/104 | |
| 24% | 25/104 | |
| 82.5% | 85/103 | |
| 80% | 84/105 | |
| 82.7% | 86/104 | |
| 83.3% | 70/84 | |
| Neurology | ||
| 57% | 61/107 | |
| 47.7% | 51/107 | |
| 62.3% | 66/106 | |
| Facial abnormalities | ||
| 54.7% | 58/106 | |
| 73.8% | 79/107 | |
| 66.4% | 71/107 | |
| 72% | 77/107 | |
| Visual and hearing impairments | ||
| 29.9% | 32/107 | |
| 46.2% | 49/106 | |
| Heart | ||
| 41.5% | 44/106 | |
| Pulmonary | ||
| 40.3% | 27/67 | |
| Gastrointestinal | ||
| 60.7% | 65/107 | |
| Urogenital | ||
| 32.1% | 34/106 | |
| Skeleton | ||
| 78.5% | 84/107 | |
| Skin / Hair / Nails | ||
| 62.3% | 66/106 | |
| Endocrine / Immunological / Metabolic | ||
| 12.1% | 13/107 | |
| 1.9% | 2/107 | |
| 10.4% | 11/106 | |
| Neoplasia | ||
| 6.6% | 7/106 | |
| Inheritance | ||
| 78.8% | 41/52 | |
ARID1A